Amgen Inc. (AMG)
XDUS
Closed
Sep 4, 2026
Day's Range
374.5052 wk Range
229.40Overview - AMG - Amgen Inc.
Key Statistics
Valuation
Enterprise Value
45.47B
P/E (Trailing)
‪26.31‬
PEG Ratio
‪0.40‬
Price / Book
‪17.42‬
EV / EBITDA
‪2.69‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪67.24%‬
Operating Margin
‪31.92%‬
Return on Assets
‪8.51%‬
Return on Equity
‪89.06%‬
Ownership
Shares Outstanding
541.00M
Price stats
50-Day Avg
‪336.71‬
200-Day Avg
‪305.33‬
Dividends
Frequency
Quarterly
Peers - AMG - Amgen Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- AMGXDUSAmgen Inc.+35.72%52-week change26.32P/E (Trailing)‪67.24%‬Profit Margin
- 6MKXDUSMerck & Co., Inc.+46.27%52-week change17.81P/E (Trailing)‪74.80%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+45.00%52-week change-13.04P/E (Trailing)‪58.75%‬Profit Margin
- BAYNXDUSBayer AG+41.69%52-week change-13.29P/E (Trailing)‪58.75%‬Profit Margin
- LLYXDUSEli Lilly and Company+38.57%52-week change43.68P/E (Trailing)‪83.04%‬Profit Margin
- IDPXDUSBiogen Inc.+38.54%52-week change21.14P/E (Trailing)‪75.69%‬Profit Margin
- JNJXDUSJohnson & Johnson+33.91%52-week change20.52P/E (Trailing)‪67.87%‬Profit Margin
Profile Summary - AMG - Amgen Inc.
About
Amgen Inc. is a global biotechnology company that discovers, develops, manufactures, and commercializes human therapeutics. Its current portfolio focuses on serious diseases across oncology, cardiovascular disease, inflammation, bone health, nephrology, and rare diseases, with medicines delivered through biologics…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
